Thymosin as a possible therapeutic drug for COVID-19: A case report

doi:10.12998/wjcc.v9.i16.4090

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 16

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5281)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

328

WORD

138

HTML

2138

Figures (1-2)

315

Sum=2919

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

370

Download

758

Sum=1128

Publishing Process of This Article

Item

Count

Browse

354

Download

880

Sum=1234

Jun 6, 2021 (publication date) through Nov 20, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Jun 6, 2021; 9(16): 4090-4094
Published online Jun 6, 2021. doi: 10.12998/wjcc.v9.i16.4090

Full Size Figure Download Figure

Figure 2 Symptoms and treatments of the patient outlined accordingly to days post symptom onset since April 27, 2020.

Citation: Zheng QN, Xu MY, Gan FM, Ye SS, Zhao H. Thymosin as a possible therapeutic drug for COVID-19: A case report. World J Clin Cases 2021; 9(16): 4090-4094
URL: https://www.wjgnet.com/2307-8960/full/v9/i16/4090.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i16.4090